VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144 | -57.0% | 18,600 | -36.5% | 0.00% | 0.0% |
| Q2 2023 | $335 | -99.9% | 29,300 | -78.0% | 0.00% | -50.0% |
| Q1 2021 | $627,000 | +13.6% | 133,200 | +72.3% | 0.00% | 0.0% |
| Q4 2020 | $552,000 | +34.0% | 77,300 | +99.7% | 0.00% | 0.0% |
| Q3 2020 | $412,000 | -15.6% | 38,700 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $488,000 | +17.6% | 38,700 | -14.8% | 0.00% | 0.0% |
| Q1 2020 | $415,000 | -34.4% | 45,400 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $633,000 | -48.7% | 45,400 | -36.8% | 0.00% | 0.0% |
| Q3 2019 | $1,234,000 | +115.0% | 71,800 | +240.3% | 0.00% | 0.0% |
| Q2 2019 | $574,000 | – | 21,100 | – | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2016 | $75,000 | -46.0% | 5,900 | -49.1% | 0.00% | -100.0% |
| Q3 2016 | $139,000 | +6.1% | 11,600 | -3.3% | 0.00% | 0.0% |
| Q2 2016 | $131,000 | +718.8% | 12,000 | +531.6% | 0.00% | – |
| Q1 2016 | $16,000 | -61.0% | 1,900 | 0.0% | 0.00% | – |
| Q4 2015 | $41,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |